background.PNG

Calendar List

Company and Drug Candidate Analysis


$PRQR - ProQR Therapeutics: What's Bigger, Its Pipeline Or Its 2019 Outlook?
Apr
1
8:30 AM08:30

$PRQR - ProQR Therapeutics: What's Bigger, Its Pipeline Or Its 2019 Outlook?

  • PRQR boasts a pipeline of 18 drug candidates, nearly all in early-stage development.

  • Cash runway to last through to 2021 following recent public offering.

  • First half of 2019 catalysts: Phase II/III ILLUMINATE trial, Phase I/II STELLAR trial with interim results mid 2019, Phase I/II adRP clinical trial, WINGS interim data.

  • Share price jumps off positive news. With a pipeline of catalysts coming up in the next 3 months,du share price is poised to take off.

View Event →